[COMPARATIVE STUDIES ON THE EFFECT OF STREPTOKINASE AND STREPTOKINASE-ACTIVATED PLASMINOGEN IN THROMBOLYTIC THERAPY].
Explore the source record for details and available documents.
SEARCH · PubMed Health
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We compared the effect between ultra-high-streptoinase therapy and standard fibrinolysis in a prospective randomized multicenter study of deep vein thrombosis. Ultra-high doses group seems to be a better treatment including decreasing the side-effects, but without showing statistical significance.
Explore the source record for details and available documents.
Explore the source record for details and available documents.